How many email patterns does GenomiCare Biotechnology use?

GenomiCare Biotechnology uses 1 known email pattern.

What domain does GenomiCare Biotechnology use for work emails?

GenomiCare Biotechnology uses genomicarebio.com for work email addresses.

Most Common Email Formats at GenomiCare Biotechnology

GenomiCare Biotechnology's most common email format is First.Last@genomicarebio.com (ex. John.Doe@genomicarebio.com), used for 100% of genomicarebio.com addresses. GenomiCare Biotechnology uses 1 email pattern.

@genomicarebio.com

1 pattern

Format	Example	Share of genomicarebio.com
First.Last@genomicarebio.comMost common	John.Doe@genomicarebio.com	100%

Need a specific person's email?

Browse GenomiCare Biotechnology's employee directory (about 18 employees) and reveal verified emails free.

Frequently Asked Questions

What does GenomiCare Biotechnology do?

GenomiCare Biotechnology was founded in 2015 and operates in the Biotechnology Research industry, alongside similar companies like MEDGENOME, Natera and SeqOne. You can visit genomicarebio.us. Explore GenomiCare Biotechnology's company overview page for more information.

What is GenomiCare Biotechnology's email address format?

GenomiCare Biotechnology's email format typically follows the pattern of First.Last@genomicarebio.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does GenomiCare Biotechnology have currently?

GenomiCare Biotechnology has approximately 18 employees as of November 2026. Key team members to contact include Director, Application Support & Business Development: R. C., Project Leader: H. C. and Bioinformatics Analyst: Y. L. For more team information and contact data, explore GenomiCare Biotechnology's employee directory with LeadIQ.

GenomiCare Biotechnology Email Format

Biotechnology ResearchJiangsu, China11-50 Employees

GenomiCare Biotechnology is a biotechnology research company focused on oncology, operating with activities in both China and the United States. It collaborates with global pharmaceutical and biotech partners to advance data-driven drug discovery and real-world oncology solutions that support the development of precision cancer therapies. 

Based in Nanjing, Jiangsu, and founded in 2015, the company works through a network of physicians across hundreds of hospitals to guide cancer patients toward personalized treatment. It relies on integrating longitudinal patient records across institutions and on in-house clinical sequencing conducted under international CLIA/CAP standards. In 2025, reports noted a leadership transition involving the founder and chief executive of GenomiCare.

Most common format

First.Last@genomicarebio.com

Example: John.Doe@genomicarebio.com

1 pattern. See all formats

Verify a GenomiCare Biotechnology email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at GenomiCare Biotechnology

@genomicarebio.com

Need a specific person's email?

Frequently Asked Questions

What does GenomiCare Biotechnology do?

What is GenomiCare Biotechnology's email address format?

How many employees does GenomiCare Biotechnology have currently?

GenomiCare Biotechnology Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.